Z_2_15 — Future of Genomics and Personalized Medicine

Genomics is undergoing a transition from research tool to clinical infrastructure. The cost of whole-genome sequencing (WGS) has plummeted from $2.7 billion (Human Genome Project, 1990–2003) to ~$200 per genome (Illumina

Z_2_13 — Pharmacogenomics and Personalized Medicine

Pharmacogenomics — the study of how genetic variation influences drug response — is among the most clinically actionable applications of human genetics. Adverse drug reactions (ADRs) are the 4th–6th leading cause of deat

Z_2_10 — Genetics of Aging and Progeria

Aging — the progressive decline in physiological function leading to increased vulnerability to disease and death — has a substantial genetic component: twin studies estimate heritability of human lifespan at ~25–30% (He

Z_2_03 — Pharmacogenomics & Ethnobotanical Genetics

Pharmacogenomics — the study of how genetic variation affects drug response — has revealed that enzymes governing drug metabolism, particularly the cytochrome P450 (CYP) superfamily, show extraordinary population-specifi

Z_2_08 — Prion Genetics and Misfolded Proteins

Prions are infectious agents composed entirely of misfolded protein — the only known pathogen that contains no nucleic acid (no DNA, no RNA). The protein-only hypothesis (Stanley Prusiner, 1982 — Nobel Prize 1997) states

Z_2_12 — Genetics of Pain Perception

Pain perception — the subjective experience triggered by actual or potential tissue damage — varies enormously across individuals, with genetic factors accounting for 25–50% of the variance in pain sensitivity (twin stud

Z_2_09 — Mitochondrial Genetics and Diseases

Human mitochondrial DNA (mtDNA) is a 16,569-bp circular genome encoding 37 genes: 13 proteins (all subunits of the oxidative phosphorylation/OXPHOS complexes I, III, IV, and V), 22 transfer RNAs, and 2 ribosomal RNAs. Un

Z_2_04 — Genetic Disorders and Inborn Errors of Metabolism

Genetic disorders — diseases caused by mutations in single genes (monogenic) or chromosomal abnormalities — affect ~3–5% of live births and collectively represent thousands of distinct conditions catalogued in the Online

Z_2_06 — Nutrigenomics and Diet-Gene Interactions

Nutrigenomics — the study of how genetic variation influences nutritional requirements, dietary responses, and disease susceptibility — and its complement nutrigenetics (how diet influences gene expression) represent a r

Z_2_00 — Medical Genetics Health: Subfolder Summary

Z_2_07 — Genetics of Disease Resistance

Infectious disease has been the most powerful selective force shaping the human genome, leaving signatures across thousands of loci. The best-understood example is sickle cell disease (HbS, Glu6Val in HBB): heterozygous

Z_1_07 — Genetic Recombination and Crossing Over

Genetic recombination — the physical exchange of DNA segments between homologous chromosomes during meiosis — is a fundamental biological process that generates genetic diversity, ensures proper chromosome segregation, a

Z_1_05 — Genomic Imprinting and Parent-of-Origin Effects

Genomic imprinting is an epigenetic phenomenon in which a gene's expression depends on whether it was inherited from the mother or the father — violating the standard Mendelian assumption that both parental copies functi

Z_1_00 — Genome Structure Organization: Subfolder Summary

Z_4_00 — RNA Protein Cell Biology: Subfolder Summary

Z_4_01 — Human Microbiome, Gut-Brain Axis, and the Holobiont Concept

The human microbiome — the ~38 trillion microbial cells (bacteria, archaea, fungi, viruses) inhabiting the human body — constitutes a co-evolved ecosystem that profoundly influences health, immunity, metabolism, developm

Z_4_03 — Forensic Genetics and DNA Identification

Forensic genetics uses DNA analysis to identify individuals, establish biological relationships, and solve criminal cases — a revolution that began when Sir Alec Jeffreys (1984, University of Leicester) discovered DNA fi

Z_4_22 — Protein Chaperone Systems

Molecular chaperones are a diverse group of proteins that assist other proteins in achieving and maintaining their correct three-dimensional structures — preventing misfolding, aggregation, and toxic accumulation of non-

Z_4_14 — RNA Interference: Gene Silencing by Small RNAs

RNA interference (RNAi) — the process by which small double-stranded RNA molecules silence gene expression by targeting complementary messenger RNA (mRNA) for degradation or translational repression — is one of the most

Z_0_00 — Molecular Biology & Genomics: Section Summary